Citadel Advisors’s Hinge Health HNGE Stock Holding History
Bought
Maintained
Sold
Other funds holding HNGE
12CM
DMC
Citadel Advisors's HNGE Position: Q2 2026 in Review
Citadel Advisors reduced its Hinge Health (HNGE) stake by 30% in Q2 2026, selling an estimated $17.7M and leaving 758,110 shares worth $62.9M. The position accounts for 0.01% of the portfolio, ranked #1347.
Citadel Advisors first reported a position in HNGE in Q2 2025 and has held it in 5 quarters since. 276 funds tracked by Wall St. Rank hold HNGE as of Q2 2026.
- Citadel Advisors held 758,110 shares of Hinge Health worth $62.9M as of Q2 2026.
- Citadel Advisors sold 325,605 Hinge Health shares in Q2 2026, an estimated $17.7M.
- Hinge Health made up 0.01% of Citadel Advisors's portfolio in Q2 2026, its #1347 holding.
- Citadel Advisors first reported a position in Hinge Health in Q2 2025 and has held it in 5 quarters since.
- 276 funds tracked by Wall St. Rank held Hinge Health as of Q2 2026.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.